Home Tags IND

Tag: IND

MabPlex

MabPlex’s Manufactured Monoclonal Antibody Receives IND Approval from the U.S. Food...

Leading Contract Development and Manufacturing Organization (CDMO) MabPlex International, serving the global biopharmaceutical and biotechnology industries with sites in China and the United States,...

Sutro Confirms IND for Second Cell-Free ADC Targeting Anti-Folate Receptor-α for...

Sutro Biopharma confirmed that the U.S. Food and Drug Administration (FDA) has concluded their 30-day review of the Investigational New Drug (IND) application for...
Manufacturing

Antibody Drug Conjugate Development: Keys to Rapid IND Submission and Approval

Antibody drug conjugates (ADCs) are a relatively new type of drug that combines the targeting ability of a biologic with a highly potent cytotoxic...
Singapore skyline

Critical Aspects of Investigational New Drug (IND) Applications: An Interview with...

EAG Laboratories is a global scientific services company providing testing, analytical and characterization services to clients across a vast array of technology- and life-science-related industries....

U.S. FDA Accepts Investigational New Drug Application for Mersana’s Lead Antibody-Drug...

The U.S. Food and Drug Administration (FDA) cleared Mersana Therapeutics’ Investigational New Drug (IND) application to begin Phase I clinical trials for its lead...

Goodwin Biotechnology partners with Aspyrian Therapeutics in Near-Infrared Photoimmunotherapy (PIT) Process...

Goodwin Biotechnology, Inc., a biological contract development and manufacturing organization or  CDMO specialized in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing mammalian cell...

FEATURED RESOURCES